183 related articles for article (PubMed ID: 23535326)
21. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
Tao M; Aimone LD; Huang Z; Mathiasen J; Raddatz R; Lyons J; Hudkins RL
J Med Chem; 2012 Jan; 55(1):414-23. PubMed ID: 22107017
[TBL] [Abstract][Full Text] [Related]
22. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
[TBL] [Abstract][Full Text] [Related]
23. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
Guryn R; Staszewski M; Kopczacki P; Walczyski K
Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560
[TBL] [Abstract][Full Text] [Related]
24. Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.
Lipani L; Odadzic D; Weizel L; Schwed JS; Sadek B; Stark H
Eur J Med Chem; 2014 Oct; 86():578-88. PubMed ID: 25218907
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation, and computational studies of Tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists.
Darras FH; Pockes S; Huang G; Wehle S; Strasser A; Wittmann HJ; Nimczick M; Sotriffer CA; Decker M
ACS Chem Neurosci; 2014 Mar; 5(3):225-42. PubMed ID: 24422467
[TBL] [Abstract][Full Text] [Related]
26. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H
Riddy DM; Cook AE; Shackleford DM; Pierce TL; Mocaer E; Mannoury la Cour C; Sors A; Charman WN; Summers RJ; Sexton PM; Christopoulos A; Langmead CJ
Neuropharmacology; 2019 Jan; 144():244-255. PubMed ID: 30359639
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.
Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL
Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490
[TBL] [Abstract][Full Text] [Related]
28. A new family of H3 receptor antagonists based on the natural product Conessine.
Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Sengupta D; Duffield JJ; Semple G; Webb RR; Sage C; Ren A; Pereira G; Knudsen J; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Whelan K; Grottick AJ
Bioorg Med Chem Lett; 2008 Feb; 18(4):1490-4. PubMed ID: 18194865
[TBL] [Abstract][Full Text] [Related]
29. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
Lepailleur A; Freret T; Lemaître S; Boulouard M; Dauphin F; Hinschberger A; Dulin F; Lesnard A; Bureau R; Rault S
J Chem Inf Model; 2014 Jun; 54(6):1773-84. PubMed ID: 24857631
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
[TBL] [Abstract][Full Text] [Related]
31. Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold.
Richter HG; Freichel C; Huwyler J; Nakagawa T; Nettekoven M; Plancher JM; Raab S; Roche O; Schuler F; Taylor S; Ullmer C; Wiegand R
Bioorg Med Chem Lett; 2010 Oct; 20(19):5713-7. PubMed ID: 20801030
[TBL] [Abstract][Full Text] [Related]
32. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and preliminary pharmacological investigation of new N-substituted-N-[ω-(ω-phenoxy-alkylpiperazin-1-yl)alkyl]guanidines as non-imidazole histamine H(3) antagonists.
Staszewski M; Walczyński K
Arch Pharm (Weinheim); 2012 Jun; 345(6):431-43. PubMed ID: 22415744
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
35. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T
J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637
[TBL] [Abstract][Full Text] [Related]
36. Optimization and preclinical evaluation of novel histamine H
Szczepańska K; Karcz T; Kotańska M; Siwek A; Kuder KJ; Latacz G; Mogilski S; Hagenow S; Lubelska A; Sobolewski M; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2018 Dec; 26(23-24):6056-6066. PubMed ID: 30448256
[TBL] [Abstract][Full Text] [Related]
37. Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
de Lera Ruiz M; Zheng J; Berlin MY; McCormick KD; Aslanian RG; West R; Hwa J; Lachowicz J; van Heek M
Bioorg Med Chem Lett; 2013 Nov; 23(21):6004-9. PubMed ID: 24035485
[TBL] [Abstract][Full Text] [Related]
38. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
[TBL] [Abstract][Full Text] [Related]
39. In silico and in vitro studies on interaction of novel non-imidazole histamine H
Podlewska S; Latacz G; Łażewska D; Kieć-Kononowicz K; Handzlik J
Bioorg Med Chem Lett; 2020 Jun; 30(11):127147. PubMed ID: 32249114
[TBL] [Abstract][Full Text] [Related]
40. Amine-constrained pyridazinone histamine H₃ receptor antagonists.
Sundar BG; Bailey T; Bacon E; Aimone L; Huang Z; Lyons J; Raddatz R; Hudkins R
Bioorg Med Chem Lett; 2011 Sep; 21(18):5543-6. PubMed ID: 21824776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
